Valacyclovir 500 Biotech 500 mg White, oblong, biconvex FC tablets.
PDF Leaflet Revision Date: 27 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of herpes zoster and recurrent genital herpes.
Dosage (summary)
Herpes zoster: 1g TID for 7 days; Genital herpes: 500mg BID for 5 days.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Not established; crosses placenta and may enter breast milk.
Key Drug Interactions
- Cimetidine
- Probenecid
- Tacrolimus
- Ciclosporin
Contraindications
- Hypersensitivity to acyclovir or valacyclovir
- Pregnancy
- Lactation
Common side effects
- Nausea
- Headaches
- Dizziness
- Rashes
Counselling Points
- Maintain hydration
- Avoid intercourse during outbreaks
- Monitor for severe skin reactions
Serious warnings
- Risk of TTP/HUS in immunocompromised patients
- Severe skin reactions
Important Disclaimer
The Valacyclovir 500 Biotech 500 mg White, oblong, biconvex FC tablets. professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
